Latest Close
$0.69
News
JSPR
Jasper Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to JSPR.
1y Change
-$2.46 (-78.16%)
Market Cap
$22,906,206.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Jasper gets a lifeline in merger with immune drugmaker Kira
BioPharma Dive • Jul 17, 2026
Read articleJasper Therapeutics Completes Merger With Kira Pharmaceuticals, Shares Fall
MT Newswires • Jul 16, 2026
Read articleJasper Therapeutics Announces Merger with Kira Pharmaceuticals
GlobeNewswire • Jul 16, 2026
Read articleChronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
PR Newswire • Jun 24, 2026
Read articleBears are Losing Control Over Jasper Therapeutics (JSPR), Here's Why It's a 'Buy' Now
Zacks • Jun 3, 2026
Read articleSector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires • Jun 1, 2026
Read article